Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-04-01

AUTHORS

Eric Tse, Anskar Y. H. Leung, Joycelyn Sim, Harold K. K. Lee, Herman S. Y. Liu, Sze-Fai Yip, Yok-Lam Kwong

ABSTRACT

Clofarabine (40 mg/m2/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m2/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (N = 4) and relapsed (N = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myelosuppression was observed in all cases, with two patients dying of bacterial sepsis. Nine patients achieved a complete remission. Disease status, number of prior therapies, and cytogenetic aberrations were not associated with the outcome. However, remission was only achieved with Ara-C at 2 g/m2/day and not 1 g/m2/day (9/15 versus 0/4, P = 0.03). More... »

PAGES

1277-1281

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-011-1223-2

DOI

http://dx.doi.org/10.1007/s00277-011-1223-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025106768

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21455604


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenine Nucleotides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arabinonucleosides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clofarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tse", 
        "givenName": "Eric", 
        "id": "sg:person.01126550300.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leung", 
        "givenName": "Anskar Y. H.", 
        "id": "sg:person.011121156664.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Princess Margaret Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415229.9", 
          "name": [
            "Department of Medicine, Princess Margaret Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sim", 
        "givenName": "Joycelyn", 
        "id": "sg:person.011416733702.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Princess Margaret Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415229.9", 
          "name": [
            "Department of Medicine, Princess Margaret Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Harold K. K.", 
        "id": "sg:person.013735624654.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013735624654.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.417134.4", 
          "name": [
            "Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Herman S. Y.", 
        "id": "sg:person.013467547564.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013467547564.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Tuen Mun Hospital, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.417336.4", 
          "name": [
            "Department of Medicine, Tuen Mun Hospital, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yip", 
        "givenName": "Sze-Fai", 
        "id": "sg:person.01134015372.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134015372.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwong", 
        "givenName": "Yok-Lam", 
        "id": "sg:person.01100514066.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-04-01", 
    "datePublishedReg": "2011-04-01", 
    "description": "Clofarabine (40\u00a0mg/m2/day\u2009\u00d7\u20095) and high-dose cytosine arabinoside (Ara-C, 1\u20132\u00a0g/m2/day\u2009\u00d7\u20095) were used in 10 men and 11 women, at a median age of 45 (22\u201362)\u2009years, with refractory (N\u2009=\u20094) and relapsed (N\u2009=\u200917) acute myeloid leukaemia, after a median of 3 (2\u20135) prior regimens. Grade 4 myelosuppression was observed in all cases, with two patients dying of bacterial sepsis. Nine patients achieved a complete remission. Disease status, number of prior therapies, and cytogenetic aberrations were not associated with the outcome. However, remission was only achieved with Ara-C at 2\u00a0g/m2/day and not 1\u00a0g/m2/day (9/15 versus 0/4, P\u2009=\u20090.03).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-011-1223-2", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "90"
      }
    ], 
    "keywords": [
      "high-dose cytosine", 
      "acute myeloid leukemia", 
      "myeloid leukemia", 
      "m2/day", 
      "grade 4 myelosuppression", 
      "treatment of refractory", 
      "prior therapy", 
      "complete remission", 
      "median age", 
      "bacterial sepsis", 
      "disease status", 
      "cytogenetic aberrations", 
      "remission", 
      "patients", 
      "clofarabine", 
      "leukemia", 
      "refractory", 
      "days", 
      "myelosuppression", 
      "sepsis", 
      "regimens", 
      "therapy", 
      "women", 
      "median", 
      "age", 
      "outcomes", 
      "men", 
      "treatment", 
      "ara", 
      "status", 
      "aberrations", 
      "years", 
      "cytosine", 
      "cases", 
      "number"
    ], 
    "name": "Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia", 
    "pagination": "1277-1281", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025106768"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-011-1223-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21455604"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-011-1223-2", 
      "https://app.dimensions.ai/details/publication/pub.1025106768"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_542.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-011-1223-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1223-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1223-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1223-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1223-2'


 

This table displays all metadata directly associated to this object as RDF triples.

211 TRIPLES      20 PREDICATES      76 URIs      68 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-011-1223-2 schema:about N1afc0de734d246f5a9f10a2d9fa5f362
2 N3c38082941704c63a7164a08467834c0
3 N4927a1ff4e644d8b95be9da4a5cbf778
4 N4b8058753cd246b2b8ce744f72522564
5 N6215238b89c44e2892b4bf259f09d70c
6 N68fcafd78cd54618b8ed52b45ef35c58
7 N76abdd92f86e4f7f87dedc8637436a5b
8 N8065e6d17e7d494191e2745d62f9331a
9 N88e281072b5742e0ad251956cc8b0a78
10 Nb7c38d22f3904922be9aa148dbddd2f8
11 Nbb3c44cc2d14495ea4cf1b65d0ef4d46
12 Nbcaa96a230bf498f92eec60370fc2976
13 Nbe811379c04d4cbc8be3204efb231d7b
14 Ne78db68a80794e9da2dd173adf0052ff
15 Nef31f80e813d450a9540f52fb6d1e8be
16 Nf4eba4546fdb4efcb50d32a3cdd19536
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author Ndaecfb7141504532a8f19854bc9f28d6
20 schema:datePublished 2011-04-01
21 schema:datePublishedReg 2011-04-01
22 schema:description Clofarabine (40 mg/m2/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m2/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (N = 4) and relapsed (N = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myelosuppression was observed in all cases, with two patients dying of bacterial sepsis. Nine patients achieved a complete remission. Disease status, number of prior therapies, and cytogenetic aberrations were not associated with the outcome. However, remission was only achieved with Ara-C at 2 g/m2/day and not 1 g/m2/day (9/15 versus 0/4, P = 0.03).
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N4a90fda6dbc24abb81901b713df48e35
26 N6bc58d1510b6480f802d293510e4d0c2
27 sg:journal.1358129
28 schema:keywords aberrations
29 acute myeloid leukemia
30 age
31 ara
32 bacterial sepsis
33 cases
34 clofarabine
35 complete remission
36 cytogenetic aberrations
37 cytosine
38 days
39 disease status
40 grade 4 myelosuppression
41 high-dose cytosine
42 leukemia
43 m2/day
44 median
45 median age
46 men
47 myeloid leukemia
48 myelosuppression
49 number
50 outcomes
51 patients
52 prior therapy
53 refractory
54 regimens
55 remission
56 sepsis
57 status
58 therapy
59 treatment
60 treatment of refractory
61 women
62 years
63 schema:name Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
64 schema:pagination 1277-1281
65 schema:productId Nd1f5b499c7ee4524a223b055ad2262f4
66 Nde455f82bb9f4a38b08e78730d0ebd24
67 Nfb8aef4da0f74a29861b3b378dc9dc1c
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025106768
69 https://doi.org/10.1007/s00277-011-1223-2
70 schema:sdDatePublished 2022-10-01T06:37
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N9e9f6035b529463796b3838bbdb3bf69
73 schema:url https://doi.org/10.1007/s00277-011-1223-2
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N146a2176a867434f9bf50785258a3882 rdf:first sg:person.01134015372.97
78 rdf:rest N2f966a1a8c0c414fb036fade6864f0ae
79 N1afc0de734d246f5a9f10a2d9fa5f362 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Recurrence
81 rdf:type schema:DefinedTerm
82 N1dae08c0bec243d794e6809667193b1d rdf:first sg:person.011416733702.66
83 rdf:rest Nc240143a178c4e3881573301716741a5
84 N2f966a1a8c0c414fb036fade6864f0ae rdf:first sg:person.01100514066.14
85 rdf:rest rdf:nil
86 N3c38082941704c63a7164a08467834c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Clofarabine
88 rdf:type schema:DefinedTerm
89 N4927a1ff4e644d8b95be9da4a5cbf778 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Cytarabine
91 rdf:type schema:DefinedTerm
92 N4a90fda6dbc24abb81901b713df48e35 schema:issueNumber 11
93 rdf:type schema:PublicationIssue
94 N4b8058753cd246b2b8ce744f72522564 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antineoplastic Combined Chemotherapy Protocols
96 rdf:type schema:DefinedTerm
97 N6215238b89c44e2892b4bf259f09d70c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Female
99 rdf:type schema:DefinedTerm
100 N68fcafd78cd54618b8ed52b45ef35c58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Adenine Nucleotides
102 rdf:type schema:DefinedTerm
103 N6bc58d1510b6480f802d293510e4d0c2 schema:volumeNumber 90
104 rdf:type schema:PublicationVolume
105 N76abdd92f86e4f7f87dedc8637436a5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Middle Aged
107 rdf:type schema:DefinedTerm
108 N8065e6d17e7d494191e2745d62f9331a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Humans
110 rdf:type schema:DefinedTerm
111 N88e281072b5742e0ad251956cc8b0a78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Arabinonucleosides
113 rdf:type schema:DefinedTerm
114 N9e9f6035b529463796b3838bbdb3bf69 schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 Na812ad0d50ae466dbb004ee45f780967 rdf:first sg:person.011121156664.42
117 rdf:rest N1dae08c0bec243d794e6809667193b1d
118 Nb7c38d22f3904922be9aa148dbddd2f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Remission Induction
120 rdf:type schema:DefinedTerm
121 Nbb3c44cc2d14495ea4cf1b65d0ef4d46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Outcome
123 rdf:type schema:DefinedTerm
124 Nbcaa96a230bf498f92eec60370fc2976 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antimetabolites, Antineoplastic
126 rdf:type schema:DefinedTerm
127 Nbe811379c04d4cbc8be3204efb231d7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Young Adult
129 rdf:type schema:DefinedTerm
130 Nc240143a178c4e3881573301716741a5 rdf:first sg:person.013735624654.87
131 rdf:rest Nd3a402aa478b4d03add3099d9a6287f2
132 Nd1f5b499c7ee4524a223b055ad2262f4 schema:name doi
133 schema:value 10.1007/s00277-011-1223-2
134 rdf:type schema:PropertyValue
135 Nd3a402aa478b4d03add3099d9a6287f2 rdf:first sg:person.013467547564.97
136 rdf:rest N146a2176a867434f9bf50785258a3882
137 Ndaecfb7141504532a8f19854bc9f28d6 rdf:first sg:person.01126550300.26
138 rdf:rest Na812ad0d50ae466dbb004ee45f780967
139 Nde455f82bb9f4a38b08e78730d0ebd24 schema:name pubmed_id
140 schema:value 21455604
141 rdf:type schema:PropertyValue
142 Ne78db68a80794e9da2dd173adf0052ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Male
144 rdf:type schema:DefinedTerm
145 Nef31f80e813d450a9540f52fb6d1e8be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Adult
147 rdf:type schema:DefinedTerm
148 Nf4eba4546fdb4efcb50d32a3cdd19536 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Leukemia, Myeloid, Acute
150 rdf:type schema:DefinedTerm
151 Nfb8aef4da0f74a29861b3b378dc9dc1c schema:name dimensions_id
152 schema:value pub.1025106768
153 rdf:type schema:PropertyValue
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1358129 schema:issn 0939-5555
161 1432-0584
162 schema:name Annals of Hematology
163 schema:publisher Springer Nature
164 rdf:type schema:Periodical
165 sg:person.01100514066.14 schema:affiliation grid-institutes:grid.415550.0
166 schema:familyName Kwong
167 schema:givenName Yok-Lam
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14
169 rdf:type schema:Person
170 sg:person.011121156664.42 schema:affiliation grid-institutes:grid.415550.0
171 schema:familyName Leung
172 schema:givenName Anskar Y. H.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42
174 rdf:type schema:Person
175 sg:person.01126550300.26 schema:affiliation grid-institutes:grid.415550.0
176 schema:familyName Tse
177 schema:givenName Eric
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26
179 rdf:type schema:Person
180 sg:person.01134015372.97 schema:affiliation grid-institutes:grid.417336.4
181 schema:familyName Yip
182 schema:givenName Sze-Fai
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134015372.97
184 rdf:type schema:Person
185 sg:person.011416733702.66 schema:affiliation grid-institutes:grid.415229.9
186 schema:familyName Sim
187 schema:givenName Joycelyn
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66
189 rdf:type schema:Person
190 sg:person.013467547564.97 schema:affiliation grid-institutes:grid.417134.4
191 schema:familyName Liu
192 schema:givenName Herman S. Y.
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013467547564.97
194 rdf:type schema:Person
195 sg:person.013735624654.87 schema:affiliation grid-institutes:grid.415229.9
196 schema:familyName Lee
197 schema:givenName Harold K. K.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013735624654.87
199 rdf:type schema:Person
200 grid-institutes:grid.415229.9 schema:alternateName Department of Medicine, Princess Margaret Hospital, Hong Kong, China
201 schema:name Department of Medicine, Princess Margaret Hospital, Hong Kong, China
202 rdf:type schema:Organization
203 grid-institutes:grid.415550.0 schema:alternateName Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
204 schema:name Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
205 rdf:type schema:Organization
206 grid-institutes:grid.417134.4 schema:alternateName Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
207 schema:name Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
208 rdf:type schema:Organization
209 grid-institutes:grid.417336.4 schema:alternateName Department of Medicine, Tuen Mun Hospital, Hong Kong, China
210 schema:name Department of Medicine, Tuen Mun Hospital, Hong Kong, China
211 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...